Mark Bullimore, PhD, MCOptom

At WSPOS Subspecialty Day during the 44th Congress of the ESCRS in London, Mark Bullimore, PhD, MCOptom, shared early trial data suggesting the Stellest 2.0 lens may slow myopic progression twice as fast as the original.

At the 44th Congress of the ESCRS in London, Mark Bullimore, PhD, MCOptom, said delaying myopia onset is more valuable than slowing its progression, and explained how to identify children most at risk.